As a result, perturbations of stress‐adaptive mechanisms that enable cancer cells to grow and survive under adverse conditions constitute a promising strategy to target KRAS‐mutant cancer (Genovese et al, 2017; Yang et al, 2019b). This evidence concerns the gene KRAS and cancer.